Navigation Links
Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer

in any 2-week period.

Cases of pure red cell aplasia (PRCA) and of severe anemia, with or without other cytopenias, associated with neutralizing antibodies to erythropoietin have been reported in patients treated with Aranesp. This has been reported predominantly in patients with CRF receiving Aranesp by subcutaneous administration. A sudden loss of response to Aranesp, accompanied by severe anemia and low reticulocyte count, should be evaluated. If anti-erythropoietin antibody-associated anemia is suspected, withhold Aranesp and other erythropoietic proteins. Aranesp should be permanently discontinued in patients with antibody-mediated anemia. Patients should not be switched to other erythropoietic proteins as antibodies may cross-react.

The most commonly reported side effects in clinical trials in patients with CRF were infection, hypertension, hypotension, myalgia, headache, and diarrhea. The most commonly reported side effects in clinical trials in patients with chemotherapy-induced anemia were fatigue, edema, nausea, vomiting, diarrhea, fever and dyspnea.

The Aranesp prescribing information, including important safety information and boxed warning, may be accessed at www.aranesp.com.

About Amgen

Amgen discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

Forward-Looking Statement

This n
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual Meeting
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
4. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
5. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
6. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
7. Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
8. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
9. CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP
10. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
11. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
Post Your Comments:
(Date:12/15/2009)... Dec. 15 Reportlinker.com announces ... is available in its catalogue: ,, ... - Market Forecasts to 2015, Competitive ... ,, http://www.reportlinker.com/p0168102/The-Future-of-HIV-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ,, ... has released its latest research "The ...
(Date:12/15/2009)... Safe Life Corp ., an innovative antimicrobial company ... spread of infection and disease, announced today that ... A400 Series respirator to help healthcare providers and ... respirators during the H1N1 pandemic. The company has ... rise in demand and now is capable of ...
(Date:12/15/2009)... -- Ghent University Hospital in Belgium, among the ... treatments using arc therapy, has carried out its ... technology from Varian Medical Systems ( VAR). A ... just 75 seconds, over four times faster than ... would have taken more than five minutes using ...
Breaking Medicine Technology:Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Reportlinker Adds The Future of HIV Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Safe Life Ramps Production Capacity of Comfortable, Breathable N95 Respirator Amid Worldwide Shortage 2Safe Life Ramps Production Capacity of Comfortable, Breathable N95 Respirator Amid Worldwide Shortage 3Safe Life Ramps Production Capacity of Comfortable, Breathable N95 Respirator Amid Worldwide Shortage 4European Radiotherapy Pioneers Deliver First Varian RapidArc(TM) Treatment for Rectal Carcinoma Patient 2European Radiotherapy Pioneers Deliver First Varian RapidArc(TM) Treatment for Rectal Carcinoma Patient 3JOIN Funding Collaborative Connects Philadelphia Workers to Living Wage Green Healthcare Jobs 47539 1JOIN Funding Collaborative Connects Philadelphia Workers to Living Wage Green Healthcare Jobs 47539 2JOIN Funding Collaborative Connects Philadelphia Workers to Living Wage Green Healthcare Jobs 47539 3JOIN Funding Collaborative Connects Philadelphia Workers to Living Wage Green Healthcare Jobs 47539 4JOIN Funding Collaborative Connects Philadelphia Workers to Living Wage Green Healthcare Jobs 47539 5BASF Sues DuPont for Patent Infringement 12397 1BASF Sues DuPont for Patent Infringement 12397 2Quest Diagnostics Introduces First Comprehensive Laboratory Test To Analyze KRAS NRAS and BRAF Gene Mutations in Reflex Testing Service 47531 1Quest Diagnostics Introduces First Comprehensive Laboratory Test To Analyze KRAS NRAS and BRAF Gene Mutations in Reflex Testing Service 47531 2Quest Diagnostics Introduces First Comprehensive Laboratory Test To Analyze KRAS NRAS and BRAF Gene Mutations in Reflex Testing Service 47531 3Quest Diagnostics Introduces First Comprehensive Laboratory Test To Analyze KRAS NRAS and BRAF Gene Mutations in Reflex Testing Service 47531 4Quest Diagnostics Introduces First Comprehensive Laboratory Test To Analyze KRAS NRAS and BRAF Gene Mutations in Reflex Testing Service 47531 5
... the Alzheimer,s Disease Market Now Available ... ... 15 Decision Resources, one of the,world,s leading research ... with Myriad Genetics/Lundbeck,s decision to,discontinue the development of Flurizan, ...
... July 15 AdvanDx today announced that a,new ... was associated with an,82% reduction in mortality rates ... unit (ICU), a 53% reduction in overall mortality ... use. The study, published in the latest issue ...
Other Medicine Technology:Bapineuzumab To Become the First-to-Market Disease-Modifying Alzheimer's Drug After Flurizan's Discontinuation 2Study Shows Use of AdvanDx's PNA FISH(TM) Test was Associated with an 82% Reduction in Intensive Care Unit Mortality Rates from Staphylococcus aureus Bloodstream Infections 2Study Shows Use of AdvanDx's PNA FISH(TM) Test was Associated with an 82% Reduction in Intensive Care Unit Mortality Rates from Staphylococcus aureus Bloodstream Infections 3Study Shows Use of AdvanDx's PNA FISH(TM) Test was Associated with an 82% Reduction in Intensive Care Unit Mortality Rates from Staphylococcus aureus Bloodstream Infections 4Study Shows Use of AdvanDx's PNA FISH(TM) Test was Associated with an 82% Reduction in Intensive Care Unit Mortality Rates from Staphylococcus aureus Bloodstream Infections 5
(Date:12/15/2009)... and the CDC have released some sobering statistics concerning the parallel ... desks offer employers an effective means of combating this trend afflicting ... ... 2009 -- Rates of diabetes are climbing across America due in ... this rise the American Diabetes Association has stated that the rate ...
(Date:12/15/2009)... 15 4R Systems, Inc., a leading ... which help retailers significantly increase profits by optimizing ... today that The Vitamin Shoppe has been utilizing ... store and DC inventory solutions have helped us ... in-stocks over the last two years," said Tony ...
(Date:12/15/2009)... The new compact LifeSpan TR200 folding treadmill, ... ), was highly praised by treadmill review groups ... The compact TR200 folding treadmill received awards for Best ... $1000. ,, The compact LifeSpan TR200 treadmill is ... spaces. "This category buster is a very compact treadmill ...
(Date:12/15/2009)... Mich. A new study links chronic obstructive pulmonary ... act as sentinels to activate the body,s immune system. ... research adds to growing awareness of the immune system,s ... affects more than 12 million Americans with wheezing, shortness ... factors is key if doctors are to find better ...
(Date:12/15/2009)... developmental changes increases risk in teens, study suggests , , ... overweight or obese increases the risk of obstructive sleep ... true for younger children, Australian researchers have found. , ... 2 to 18, who were referred for evaluation of ... that among those aged 12 and older the risk ...
Breaking Medicine News(10 mins):Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 2Health News:TrekDesk: A Potentially Positive Impact on Diabetes & Obesity 3Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 2Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 3Health News:4R's Profit Optimizing Inventory Solutions Helps The Vitamin Shoppe Drive Increased Productivity and Performance 4Health News:Treadmill Reviews Rate Compact LifeSpan Treadmill Best Treadmill 2Health News:Immune cell activity linked to worsening COPD 2Health News:Immune cell activity linked to worsening COPD 3Health News:Puberty May Trigger Sleep Apnea in Overweight Kids 2
... A study by the American Psychological Association (APA) has ... girls and young// women in advertising and media is ... ,To complete the report, the APA Task Force on ... content and effects of virtually every form of media, ...
... fun form of exercise and play but can pose a ... to a new Swedish study. ,The increase of ... head injuries" that could occur, Ulf Bjornstig of the Umea ... ,The most common injuries were, however, sprains and ...
... traced dead domestic poultry in several districts of suburban Moscow ... have tightened quarantines following confirmation of the presence of the ... to be recorded so close to the Russian capital. ... birds that were purchased at a market located just outside ...
... cases growing by leaps and bounds in Indonesia//, and announced a ... regions. , Talking numbers are frightening –there ... HIV cases in the most populous Muslim nation of the world, ... ,Higher incidences are seen among a special group- drug addicts and ...
... is under pressure- he is asked to respond to allegations ... Hospital, which ‘cares’ for people with learning and mental disabilities. ... around 100 adults and 17 children, is now under police ... patient sent a letter of complaint to the North and ...
... A parasite, which deforms the spines and skulls of trout causing ... hatcheries in West Maryland, U.S. The disease is referred to as ... in the plan to cull around 80,000 of the fresh water ... to exist in the Potomac River's North Branch, which are several ...
Other Medicine News:Health News:Sexualization Linked to Mental Health Problems in Girls and Women 2Health News:Russia’s Avian Flu Outbreak Linked to Single Marke 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: